Isocyanates
Medchemexpress LLC FG-3019 10mg | 10mg
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF) FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF)[1][2]
Medchemexpress LLC FG-3019 1mg | 1mg
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF) FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF)[1][2]
Aobchem 5-Bromo-2-hydroxy-3-methylbenzoic acid | ≥97% | CAS 36194-82-8 | C8H7BrO3 | 10g
5-Bromo-2-hydroxy-3-methylbenzoic acid | ≥97% | CAS 36194-82-8 | C8H7BrO3 | 10g
Aobchem 2-Bromo-3-methoxy-6-methylbenzaldehyde | ≥97% | CAS 1780038-16-5 | C9H9BrO2 | 500mg
2-Bromo-3-methoxy-6-methylbenzaldehyde | ≥97% | CAS 1780038-16-5 | C9H9BrO2 | 500mg
Aobchem 1-Bromo-2-methoxy-3-methylbenzene | ≥97% | CAS 52200-69-8 | C8H9BrO | 5g
1-Bromo-2-methoxy-3-methylbenzene | ≥97% | CAS 52200-69-8 | C8H9BrO | 5g
Aobchem 1-Bromo-2-methoxy-4-methylbenzene | ≥97% | CAS 95740-49-1 | C8H9BrO | 25g
1-Bromo-2-methoxy-4-methylbenzene | ≥97% | CAS 95740-49-1 | C8H9BrO | 25g
Aobchem 6-Chloro-2-fluoro-3-methylbenzaldehyde | ≥97% | CAS 286474-59-7 | C8H6ClFO | 25g
6-Chloro-2-fluoro-3-methylbenzaldehyde | ≥97% | CAS 286474-59-7 | C8H6ClFO | 25g
Aobchem 3-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 207681-67-2 | C9H10BrNO2 | 5g
3-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 207681-67-2 | C9H10BrNO2 | 5g
Aobchem 6-Chloro-2-fluoro-3-methylbenzaldehyde | ≥97% | CAS 286474-59-7 | C8H6ClFO | 10g
6-Chloro-2-fluoro-3-methylbenzaldehyde | ≥97% | CAS 286474-59-7 | C8H6ClFO | 10g
Aobchem 4-Chloro-2-fluoro-3-methylbenzonitrile | ≥97% | CAS 1207875-88-4 | C8H5ClFN | 1g
4-Chloro-2-fluoro-3-methylbenzonitrile | ≥97% | CAS 1207875-88-4 | C8H5ClFN | 1g
eMolecules 622-58-2 | P-Tolyl isocyanate | Combi-Blocks | MFCD00002029 | 133.150 | C8H7NO | 98.000 | Cc1ccc(cc1)N=C=O | 1g | 388715425
P-Tolyl isocyanate | Combi-Blocks | 622-58-2 | MFCD00002029 | 133.150 | C8H7NO | 98.000 | Cc1ccc(cc1)N=C=O | 1g | 388715425
Cayman Chemical 14 15EpETE Fatty Acids and Der
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.{6485,7204} CYP450 metabolism of PUFAs, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator.{5826} However, the CYP450 metabolites of EPA (Item No. 90110) and DHA (Item No. 90310) have been little studied relative to arachidonate epoxygenase metabolites. (±)14(15)-EpETE is the ω-3 homolog of (±)14(15)-EpETrE, derived via epoxidation of the 14,15-double bond of EPA. The EDHF activity of (±)14(15)-EpETE has not yet been determined.
Cayman Chemical 14 15EpETE Fatty Acids and Der
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.{6485,7204} CYP450 metabolism of PUFAs, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator.{5826} However, the CYP450 metabolites of EPA (Item No. 90110) and DHA (Item No. 90310) have been little studied relative to arachidonate epoxygenase metabolites. (±)14(15)-EpETE is the ω-3 homolog of (±)14(15)-EpETrE, derived via epoxidation of the 14,15-double bond of EPA. The EDHF activity of (±)14(15)-EpETE has not yet been determined.
Cayman Chemical 19 20EpDPA Fatty Acids and Der
An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; suppresses hCLS formation and liver fibrosis in wild-type mice in a model of NASH at 100 ng/animal, i.p., intraplantar administration induces acute mechanical hyperalgesia in mice